Health care stocks edged up late Monday afternoon, with the NYSE Health Care Index adding 0.3% and the Health Care Select Sector SPDR Fund (XLV) up 0.2%.
The iShares Biotechnology ETF (IBB) gained 0.9%.
In corporate news, PROCEPT BioRobotics (PRCT) shares surged past 31% after the company released Q3 results that were above market expectations and raised its revenue outlook for 2024.
Monte Rosa Therapeutics (GLUE) shares soared 98%. The company said Monday that it signed a global development and commercialization license agreement with Novartis (NVS) for VAV1-directed molecular glue degraders, including MRT-6160. Novartis shares rose 1.7%.
Vera Therapeutics (VERA) shares jumped past 15% after the company disclosed long-term efficacy and favorable safety data from its phase 2b trial of kidney disease treatment candidate atacicept.
Royal Philips (PHG) shares tumbled past 16%. The company cut its full-year comparable sales growth outlook amid a substantial drop in demand in China, while Q3 earnings were little changed.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。